(+)-pilocarpine multiple interactions EXP 6480464 [Lithium Chloride co-treated with Pilocarpine] results in decreased expression of RECK mRNA, [Lithium Chloride co-treated with Pilocarpine] results in decreased expression of RECK protein CTD PMID:31018114 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1318851 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RECK mRNA CTD PMID:22079256 1,1-dichloroethene decreases expression ISO RGD:1318852 6480464 vinylidene chloride results in decreased expression of RECK mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression ISO RGD:1318852 6480464 1, 2-Dimethylhydrazine results in decreased expression of RECK mRNA CTD PMID:22206623 17beta-estradiol multiple interactions ISO RGD:1318851 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of RECK mRNA CTD PMID:20660070 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:1318852 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1318852 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to RECK gene] CTD PMID:20819909 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of RECK mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1318851 6480464 Tetrachlorodibenzodioxin results in decreased expression of RECK mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of RECK mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1318852 6480464 Tetrachlorodibenzodioxin results in increased expression of RECK mRNA CTD PMID:20819909 2-methoxyethanol increases expression EXP 6480464 methyl cellosolve results in increased expression of RECK mRNA CTD PMID:21061450 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1318851 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RECK mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RECK mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:1318852 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of RECK mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO RGD:1318852 6480464 Fenretinide results in decreased expression of RECK mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1318851 6480464 [Decitabine affects the methylation of RECK promoter] which affects the expression of RECK mRNA more ... CTD PMID:17443689 , PMID:21167264 5-aza-2'-deoxycytidine affects expression ISO RGD:1318851 6480464 Decitabine affects the expression of RECK mRNA CTD PMID:17233834 5-aza-2'-deoxycytidine affects methylation ISO RGD:1318851 6480464 Decitabine affects the methylation of RECK promoter CTD PMID:17443689 acetamide increases expression EXP 6480464 acetamide results in increased expression of RECK mRNA CTD PMID:31881176 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of RECK mRNA CTD PMID:28959563 aflatoxin B1 affects expression ISO RGD:1318851 6480464 Aflatoxin B1 affects the expression of RECK protein CTD PMID:20106945 all-trans-retinoic acid increases expression ISO RGD:1318852 6480464 Tretinoin results in increased expression of RECK mRNA CTD PMID:16604517 all-trans-retinoic acid increases expression ISO RGD:1318851 6480464 Tretinoin results in increased expression of RECK mRNA CTD PMID:23724009 antirheumatic drug increases expression ISO RGD:1318851 6480464 Antirheumatic Agents results in increased expression of RECK mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:1318851 6480464 aristolochic acid I results in decreased expression of RECK mRNA CTD PMID:33212167 atrazine decreases expression ISO RGD:1318851 6480464 Atrazine results in decreased expression of RECK mRNA CTD PMID:22378314 azathioprine decreases expression ISO RGD:1318851 6480464 Azathioprine results in decreased expression of RECK mRNA CTD PMID:22623647 benzo[a]pyrene decreases expression ISO RGD:1318851 6480464 Benzo(a)pyrene results in decreased expression of RECK mRNA CTD PMID:21632981 bisphenol A increases expression ISO RGD:1318852 6480464 bisphenol A results in increased expression of RECK mRNA CTD PMID:21932408 , PMID:30951980 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of RECK mRNA CTD PMID:30816183 , PMID:34947998 bisphenol A multiple interactions ISO RGD:1318851 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of RECK gene, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RECK mRNA CTD PMID:28628672 , PMID:31601247 bisphenol F multiple interactions ISO RGD:1318851 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RECK mRNA CTD PMID:28628672 bisphenol F increases expression ISO RGD:1318852 6480464 bisphenol F results in increased expression of RECK mRNA CTD PMID:30951980 calcium dichloride increases expression ISO RGD:1318851 6480464 Calcium Chloride results in increased expression of RECK protein CTD PMID:25824407 carbon nanotube decreases expression ISO RGD:1318852 6480464 Nanotubes more ... CTD PMID:25554681 chlorpyrifos increases expression ISO RGD:1318852 6480464 Chlorpyrifos results in increased expression of RECK mRNA CTD PMID:20350560 cisplatin increases expression ISO RGD:1318852 6480464 Cisplatin results in increased expression of RECK mRNA CTD PMID:21151649 cocaine increases expression ISO RGD:1318851 6480464 Cocaine results in increased expression of RECK protein CTD PMID:18000554 copper(II) sulfate decreases expression ISO RGD:1318851 6480464 Copper Sulfate results in decreased expression of RECK mRNA CTD PMID:19549813 crocidolite asbestos decreases expression ISO RGD:1318852 6480464 Asbestos, Crocidolite results in decreased expression of RECK mRNA CTD PMID:29279043 cumene decreases expression ISO RGD:1318852 6480464 cumene results in decreased expression of RECK mRNA CTD PMID:18648096 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of RECK mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO RGD:1318851 6480464 Cyclosporine results in decreased expression of RECK mRNA CTD PMID:25562108 , PMID:27989131 dexamethasone multiple interactions ISO RGD:1318851 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RECK mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RECK mRNA CTD PMID:28628672 dioxygen multiple interactions ISO RGD:1318852 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RECK mRNA CTD PMID:30529165 diuron decreases expression EXP 6480464 Diuron results in decreased expression of RECK mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:1318851 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RECK mRNA CTD PMID:27188386 elemental selenium decreases expression ISO RGD:1318851 6480464 Selenium results in decreased expression of RECK mRNA CTD PMID:19244175 ellagic acid multiple interactions ISO RGD:1318851 6480464 zinc chloride inhibits the reaction [Ellagic Acid results in increased expression of RECK mRNA], zinc chloride inhibits the reaction [Ellagic Acid results in increased expression of RECK protein] CTD PMID:21573219 ellagic acid increases expression ISO RGD:1318851 6480464 Ellagic Acid results in increased expression of RECK mRNA, Ellagic Acid results in increased expression of RECK protein CTD PMID:21573219 emetine decreases expression ISO RGD:1318851 6480464 Emetine results in decreased expression of RECK mRNA CTD PMID:26332055 entinostat increases expression ISO RGD:1318851 6480464 entinostat results in increased expression of RECK mRNA CTD PMID:27188386 eugenol multiple interactions EXP 6480464 Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of RECK mRNA], Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of RECK protein] CTD PMID:20434464 fenvalerate decreases expression EXP 6480464 fenvalerate results in decreased expression of RECK mRNA CTD PMID:30307764 fluoranthene multiple interactions ISO RGD:1318852 6480464 [1-methylanthracene co-treated with fluoranthene] results in decreased expression of RECK mRNA CTD PMID:28329830 folic acid affects expression ISO RGD:1318851 6480464 Folic Acid affects the expression of RECK mRNA CTD PMID:17320366 folic acid decreases expression ISO RGD:1318852 6480464 Folic Acid results in decreased expression of RECK mRNA CTD PMID:25629700 folic acid decreases expression ISO RGD:1318851 6480464 Folic Acid results in decreased expression of RECK mRNA CTD PMID:21867686 fulvestrant multiple interactions ISO RGD:1318851 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of RECK gene CTD PMID:31601247 hydrogen peroxide multiple interactions ISO RGD:1318851 6480464 [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of RECK protein CTD PMID:18951874 hydroquinone decreases expression ISO RGD:1318851 6480464 hydroquinone results in decreased expression of RECK mRNA CTD PMID:31256213 indometacin multiple interactions ISO RGD:1318851 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RECK mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RECK mRNA CTD PMID:28628672 irinotecan increases expression ISO RGD:1318851 6480464 Irinotecan analog results in increased expression of RECK mRNA CTD PMID:18927307 lithium chloride multiple interactions EXP 6480464 [Lithium Chloride co-treated with Pilocarpine] results in decreased expression of RECK mRNA, [Lithium Chloride co-treated with Pilocarpine] results in decreased expression of RECK protein CTD PMID:31018114 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions EXP 6480464 Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of RECK mRNA], Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of RECK protein] CTD PMID:20434464 N-methyl-N'-nitro-N-nitrosoguanidine decreases expression EXP 6480464 Methylnitronitrosoguanidine results in decreased expression of RECK mRNA, Methylnitronitrosoguanidine results in decreased expression of RECK protein CTD PMID:20434464 N-nitrosodiethylamine multiple interactions ISO RGD:1318852 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of RECK mRNA CTD PMID:24535843 nickel atom decreases expression ISO RGD:1318851 6480464 Nickel results in decreased expression of RECK mRNA CTD PMID:25583101 nickel dichloride multiple interactions ISO RGD:1318851 6480464 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [nickel chloride results in decreased expression of RECK protein] more ... CTD PMID:26026961 nickel dichloride decreases expression ISO RGD:1318851 6480464 nickel chloride results in decreased expression of RECK protein CTD PMID:26026961 nickel sulfate decreases expression ISO RGD:1318851 6480464 nickel sulfate results in decreased expression of RECK mRNA CTD PMID:22714537 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of RECK mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of RECK mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1318852 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of RECK mRNA CTD PMID:34911549 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of RECK mRNA CTD PMID:33387578 perfluorononanoic acid decreases expression ISO RGD:1318851 6480464 perfluoro-n-nonanoic acid results in decreased expression of RECK mRNA CTD PMID:32588087 phenobarbital multiple interactions ISO RGD:1318852 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of RECK mRNA CTD PMID:24535843 phenobarbital affects expression ISO RGD:1318852 6480464 Phenobarbital affects the expression of RECK mRNA CTD PMID:23091169 phenylmercury acetate decreases expression ISO RGD:1318851 6480464 Phenylmercuric Acetate results in decreased expression of RECK mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1318851 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RECK mRNA CTD PMID:27188386 potassium chromate multiple interactions ISO RGD:1318851 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RECK mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:1318851 6480464 potassium chromate(VI) results in decreased expression of RECK mRNA CTD PMID:22079256 progesterone multiple interactions ISO RGD:1318851 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of RECK mRNA CTD PMID:20660070 quercetin increases expression ISO RGD:1318851 6480464 Quercetin results in increased expression of RECK mRNA CTD PMID:21632981 resveratrol decreases expression ISO RGD:1318851 6480464 resveratrol results in decreased expression of RECK protein CTD PMID:18089832 SB 431542 multiple interactions ISO RGD:1318851 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RECK mRNA CTD PMID:27188386 selenium atom decreases expression ISO RGD:1318851 6480464 Selenium results in decreased expression of RECK mRNA CTD PMID:19244175 silicon dioxide decreases expression ISO RGD:1318851 6480464 Silicon Dioxide analog results in decreased expression of RECK mRNA CTD PMID:25895662 sodium arsenite multiple interactions ISO RGD:1318851 6480464 decitabine inhibits the reaction [sodium arsenite results in decreased expression of RECK mRNA] more ... CTD PMID:21167264 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of RECK protein CTD PMID:21167264 sodium arsenite increases methylation ISO RGD:1318851 6480464 sodium arsenite results in increased methylation of RECK promoter CTD PMID:21167264 sodium arsenite decreases expression ISO RGD:1318851 6480464 sodium arsenite results in decreased expression of RECK mRNA, sodium arsenite results in decreased expression of RECK protein CTD PMID:21167264 solasodine increases expression ISO RGD:1318851 6480464 solasodine results in increased expression of RECK mRNA CTD PMID:28283413 sunitinib decreases expression ISO RGD:1318851 6480464 Sunitinib results in decreased expression of RECK mRNA CTD PMID:31533062 tetrachloromethane affects expression ISO RGD:1318852 6480464 Carbon Tetrachloride affects the expression of RECK mRNA CTD PMID:17484886 tetrachloromethane increases expression ISO RGD:1318852 6480464 Carbon Tetrachloride results in increased expression of RECK mRNA CTD PMID:31919559 theophylline multiple interactions ISO RGD:1318851 6480464 [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of RECK protein CTD PMID:18951874 titanium dioxide affects expression ISO RGD:1318852 6480464 titanium dioxide affects the expression of RECK mRNA CTD PMID:17656681 titanium dioxide decreases expression ISO RGD:1318852 6480464 titanium dioxide results in decreased expression of RECK mRNA CTD PMID:29264374 tomatidine increases expression ISO RGD:1318851 6480464 tomatidine results in increased expression of RECK mRNA CTD PMID:23566884 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of RECK mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of RECK mRNA CTD PMID:25729387 trichostatin A increases expression ISO RGD:1318851 6480464 trichostatin A results in increased expression of RECK mRNA CTD PMID:24935251 trichostatin A affects expression ISO RGD:1318851 6480464 trichostatin A affects the expression of RECK mRNA CTD PMID:28542535 urethane decreases expression ISO RGD:1318852 6480464 Urethane results in decreased expression of RECK mRNA CTD PMID:16289808 Ursonic acid affects expression ISO RGD:1318851 6480464 ursonic acid affects the expression of RECK mRNA CTD PMID:31790661 valproic acid decreases expression ISO RGD:1318851 6480464 Valproic Acid results in decreased expression of RECK mRNA CTD PMID:23179753 , PMID:24383497 valproic acid increases expression ISO RGD:1318851 6480464 Valproic Acid results in increased expression of RECK mRNA CTD PMID:19101580 , PMID:24935251 zinc dichloride multiple interactions ISO RGD:1318851 6480464 zinc chloride inhibits the reaction [Ellagic Acid results in increased expression of RECK mRNA], zinc chloride inhibits the reaction [Ellagic Acid results in increased expression of RECK protein] CTD PMID:21573219
